Tissue-specific synthesis and oxidative metabolism of estrogens.
about
Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.Oestrogen exposure and breast cancer riskInduction of oxidative stress responses by dioxin and other ligands of the aryl hydrocarbon receptorAtrazine and breast cancer: a framework assessment of the toxicological and epidemiological evidenceQuantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostateTetra-methoxystilbene modulates ductal growth of the developing murine mammary gland.CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma.Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells.Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.Estrogen metabolism by cytochrome P450 1B1 modulates the hypertensive effect of angiotensin II in female miceAntioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats.L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL ratsRoles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor statusSerum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women.Potential mechanisms of estrogen quinone carcinogenesis.Ovarian susceptibility to benzo[a]pyrene: tissue burden of metabolites and DNA adducts in F-344 ratsAssay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry.How to reduce your cancer risk: mechanisms and myths.Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants.Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studiesMechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A reviewEstrogens and prostate cancer: etiology, mediators, prevention, and management.Cytochrome P450 1B1: An unexpected modulator of liver fatty acid homeostasisDepurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancerUrinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.How can grafted breast cancer models be optimized?Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesisIdentification of mammary epithelial cells subject to chronic oxidative stress in mammary epithelium of young women and teenagers living in USA: implication for breast carcinogenesis.CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance.The role of estrogens in prostate carcinogenesis: a rationale for chemoprevention.Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancerPremenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study IICirculating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.Genetic polymorphisms in CYP1A1, CYP1B1 and COMT genes in Greenlandic Inuit and EuropeansTARGETING THE GENOTOXIC EFFECTS OF ESTROGENS.Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes.Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus.
P2860
Q24796091-D51902B2-0B10-41EC-8BFB-03BBADDC4300Q24803498-B0DF2168-B4D3-4CB9-A173-D4430F74CAE7Q28384931-A59FD771-6AEA-4F47-BD72-6B481D47F40CQ28392184-20881846-3D10-4CC5-A8AC-A8815ACBBBBCQ28755344-D29081EB-F1CE-4A1C-8D9D-DB27BD805B88Q30393970-31484455-1D47-4778-9A9D-4C24748B72F9Q30440774-87ACEB4D-3746-4F4A-B32F-C27901B01CDDQ31149230-726C78FC-4D24-4373-B046-88DBAF9D9428Q33708061-77A9942F-FDE0-44CC-9BCC-ADE709F1C762Q33770803-273A18C6-EAFA-4415-913D-F5E51B87A5E4Q33787147-D84241BB-8BB8-421E-9737-9F90A52FD865Q33889022-8217D272-047B-42AD-8A92-ECB3E3B79F98Q34025688-E95D8C79-99D1-47B8-8F96-C6FB3EADD626Q34213076-42C52197-7FB6-4535-B54B-694D82AC2AB0Q34310409-63F80B3E-129F-4006-A58F-26C1E6DBF9D4Q34720369-3EFACA1F-1AB0-4773-8C43-C15301062136Q34799433-6FB25929-8EA2-46DB-9C48-A3B180830144Q34893614-4E0519F0-5189-4395-91FE-F01DBBBF8D95Q34894797-EA790187-1A3E-46E0-888B-C056A30CA0BAQ34983069-02EEC5D0-0CFD-4327-A836-9391867AD52BQ35092205-D6676BC0-B2A5-4549-B0CF-FD5B7466DC43Q35118917-042DB908-D685-48C0-A2D9-9A439EEC7F87Q35196710-46E5B017-10B0-4A11-8D56-5C334908165BQ35295747-9FA3633F-2134-4B87-8A01-F9C0990BA9D1Q35575724-B40B8693-9D61-44D6-9DAA-E76B599FBDE2Q35620661-6178E9F9-4A96-4717-8838-4216EDCD9846Q35729908-F56D400A-36B2-4BB0-9951-921F56B4EEABQ35747349-BBA0018A-A8F7-4099-8521-385314048A0EQ35760911-68E529FE-3D94-4778-A4C5-ECFD3C487E28Q35881326-F9B29216-F614-4164-9E6D-1522F7DF65E0Q35911651-A8B10BFD-54E3-4B3E-95A6-A6D13BBB3FE8Q36459804-238EB795-9E25-453E-87ED-314544944507Q36598404-5894EA1B-1E06-4AE0-BE03-2756278C18FBQ36889935-8ADBC61C-BF8F-42BA-AE2D-BE319F1F8605Q36903340-AF7D3347-091C-4798-97A0-9DAA2C898883Q36925454-7A52FA31-4EBE-4ECA-8BF4-FD909818EA1FQ36930545-A8DF1A4A-9317-4924-A66F-03694A81CAFEQ36936984-3E572B44-C313-4CD4-AC25-C32C3978AF19Q36990958-0B318633-0300-4CEC-BD87-FC107D371FA5Q37136803-34DEFA39-43BC-4F49-AF14-4A99D437F260
P2860
Tissue-specific synthesis and oxidative metabolism of estrogens.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tissue-specific synthesis and oxidative metabolism of estrogens.
@ast
Tissue-specific synthesis and oxidative metabolism of estrogens.
@en
Tissue-specific synthesis and oxidative metabolism of estrogens.
@nl
type
label
Tissue-specific synthesis and oxidative metabolism of estrogens.
@ast
Tissue-specific synthesis and oxidative metabolism of estrogens.
@en
Tissue-specific synthesis and oxidative metabolism of estrogens.
@nl
prefLabel
Tissue-specific synthesis and oxidative metabolism of estrogens.
@ast
Tissue-specific synthesis and oxidative metabolism of estrogens.
@en
Tissue-specific synthesis and oxidative metabolism of estrogens.
@nl
P2093
P1476
Tissue-specific synthesis and oxidative metabolism of estrogens
@en
P2093
C R Jefcoate
F Naftolin
L Berstein
R J Santen
P304
P356
10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A024248
P577
2000-01-01T00:00:00Z